Lin Jinbing
Stories by Lin Jinbing
Danish biotech giant Genmab to buy Lilly Asia-backed ProfoundBio for $1.8b
ProfoundBio is also backed by LYFE Capital and HongShan.
China, Singapore widen investor access to each other’s stock markets through ETFs
The two ETFs that listed on Friday have a combined AUM of over $200m.
Foreign investment in China hits record amid strong post-pandemic recovery
In the first and second quarters, net inflows reached $232.2 billion and $210.6 billion, respectively.
Ant Group said to seek $30b in record-shattering IPO
Ant Group plans to sell 10% of its shares in Shanghai and another 5% in Hong Kong.
Chinese battery maker CATL raises $2.8b from UBS, JPMorgan, others
Hillhouse Capital contributed 10 billion yuan, more than half of the total funding.
Luckin founder Lu Zhengyao to face criminal charges for financial fraud
China’s top market watchdog and MoF have found evidence that Luckin paid taxes on bogus transactions.
